PMCB
PMCB
NASDAQ · Biotechnology

Pharmacyte Biotech Inc

$0.71
0.00 (-0.37%)
Financial Highlights (FY 2025)
Revenue
1.57M
Net Income
4.2K
Gross Margin
32.9%
Profit Margin
0.3%
Rev Growth
-8.5%
D/E Ratio
0.92
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 32.9% 32.9% 32.9%
Operating Margin 0.4% 0.4% 0.4%
Profit Margin 0.3% 0.4% 0.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.57M 1.60M 1.25M
Gross Profit 517.4K 525.5K 411.5K
Operating Income 6.9K 6.1K 4.9K
Net Income 4.2K 5.8K 3.4K
Gross Margin 32.9% 32.9% 32.9%
Operating Margin 0.4% 0.4% 0.4%
Profit Margin 0.3% 0.4% 0.3%
Rev Growth -8.5% +15.0% -6.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 3.28M 2.87M 3.13M
Total Equity 3.56M 3.27M 3.26M
D/E Ratio 0.92 0.88 0.96
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 8.2K 8.5K 6.5K
Free Cash Flow 4.7K 4.2K 2.8K